関連する実験動画

Updated: Jul 17, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

血清と血の総コレステロールの差異:どのような補正因子を使うべきか?

G G Wickus, R O Dukerschein

    JAMA
    |January 8, 1992
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    Assessing Whole-Body Lipid-Handling Capacity in Mice
    07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    関連する実験動画

    Last Updated: Jul 17, 2026

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
    13:08

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

    Published on: September 9, 2012

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    Assessing Whole-Body Lipid-Handling Capacity in Mice
    07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    関連する概念動画

    Buffer Effectiveness02:19

    Buffer Effectiveness

    Buffer solutions do not have an unlimited capacity to keep the pH relatively constant . Instead, the ability of a buffer solution to resist changes in pH relies on the presence of appreciable amounts of its conjugate weak acid-base pair. When enough strong acid or base is added to substantially lower the concentration of either member of the buffer pair, the buffering action within the solution is compromised.
    The buffer capacity is the amount of acid or base that can be added to a given volume...
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    The rapid low-dose (1 microgram) cosyntropin test in the immediate postoperative period: results in elderly subjects after major abdominal surgery.

    Surgery·1999

    Serum parathyroid hormone-related protein levels during lactation.

    The Journal of reproductive medicine·1995

    Postoperative acute adrenal failure caused by transient corticotropin deficiency.

    Surgery·1994

    Subclinical hormone secretion by incidentally discovered adrenal masses.

    Archives of surgery (Chicago, Ill. : 1960)·1994

    Reduced calcitriol requirements for treating hypoparathyroidism during lactation. A case report.

    The Journal of reproductive medicine·1993

    Transient corticotropin deficiency in critical illness.

    Mayo Clinic proceedings·1993

    Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment.

    JAMA·2026

    Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial.

    JAMA·2026

    Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

    JAMA·2026

    Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease.

    JAMA·2026

    YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer: A Randomized Clinical Trial.

    JAMA·2026

    Clinical, organizational and institutional levers to ensure low-coercion psychiatry: an ethnographic study of four French psychiatric hospitals.

    Social science & medicine (1982)·2026

    Toward a new tool for risk-assessment: recidivism of child sexual abuse materials in men under voluntary treatment.

    Frontiers in psychology·2026

    Risk assessment instruments for predicting the risk of sexual recidivism: A meta-analytic comparison of 10 instruments.

    Psychological assessment·2026

    Identity-based prosocial motivation protects detained youth against institutional infractions.

    Law and human behavior·2026

    A Legal Framework for Reducing Violence in Healthcare Institutions: A Comparative Study and Policy Recommendations.

    Asian bioethics review·2026

    Trauma Profiles and Cocaine Use Among Formerly Incarcerated Black Men Who Co-Use Opioids and Stimulants.

    The Journal of black psychology·2026
    関連記事をすべて見る
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    JoVEについて
    概要リーダーシップブログJoVEヘルプセンター
    著者向け
    出版プロセス編集委員会範囲と方針査読よくある質問投稿
    図書館員向け
    推薦の声購読アクセスリソース図書館諮問委員会よくある質問
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
    利用規約
    プライバシーポリシー
    ポリシー
    Jove
    Visualize
    お問い合わせ